Grants paid by Kidney Cancer Research Alliance Inc
EIN 81-2067843 · Alexandria, VA · Form 990, Schedule I · NTEE T30
Kidney Cancer Research Alliance Inc of Alexandria, VA (EIN 81-2067843) reported 7 grants paid totaling $369,297 to 6 recipients in tax years 2018–2024, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$369,297
7 grants
Recipients
6
distinct organizations
Tax years
2018–2024
5 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2018 | 1 | $50,000 | — |
| 2020 | 2 | $144,297 | — |
| 2022 | 1 | $50,000 | — |
| 2023 | 1 | $50,000 | — |
| 2024 | 2 | $75,000 | — |
Top recipients
The 6 recipients receiving the most from Kidney Cancer Research Alliance Inc, by grants paid, out of 6 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Brigham & Womens Hospital 04-2312909 | A | Boston, MA | 2 | $100,000 | 2024 |
| Ut Southwest Medical Center 75-6002868 | A | Dallas, TX | 1 | $94,297 | 2020 |
| Memorial Sloan Kettering Cancer Ctr 13-1624082 | A | New York, NY | 1 | $50,000 | 2022 |
| Dana-Farber Institute 04-2263040 | A | Boston, MA | 1 | $50,000 | 2018 |
| Thomas Jefferson University 23-1352651 | A | Philadelphia, PA | 1 | $50,000 | 2020 |
| Md Anderson 74-6001118 | A | Houston, TX | 1 | $25,000 | 2024 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 7 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Brigham & Womens Hospital Boston, MA | A | $50,000 | paid | CANCER RESEARCH | 202533179349305793 |
| 2024 | Md Anderson Houston, TX | A | $25,000 | paid | CANCER RESEARCH | 202533179349305793 |
| 2023 | Brigham & Womens Hospital Boston, MA | A | $50,000 | paid | CANCER RESEARCH | 202433189349311203 |
| 2022 | Memorial Sloan Kettering Cancer Ctr New York, NY | A | $50,000 | paid | CANCER RESEARCH | 202323199349303462 |
| 2020 | Ut Southwest Medical Center Dallas, TX | A | $94,297 | paid | Cancer research | 202123009349301747 |
| 2020 | Thomas Jefferson University Philadelphia, PA | A | $50,000 | paid | Investigation of anti-tumor effect | 202123009349301747 |
| 2018 | Dana-Farber Institute Boston, MA | A | $50,000 | paid | Award for research in CAR T cells | 201932329349300633 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990 | 2024 | 2024-12-31 | not stated | 2024v5.2 | 202533179349305793 |
| 990 | 2023 | 2023-12-31 | not stated | 2023v5.1 | 202433189349311203 |
| 990 | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202323199349303462 |
| 990 | 2020 | 2020-12-31 | not stated | 2020v4.0 | 202123009349301747 |
| 990 | 2018 | 2018-12-31 | not stated | 2018v3.1 | 201932329349300633 |
Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/812067843.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.